Shareholders that lost money on Sarepta Therapeutics, Inc.(SRPT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

NEW YORK, Aug. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Sarepta Therapeutics, Inc. ("Sarepta" or the "Company") (NASDAQ: SRPT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Sarepta investors who were...